Given the increasing exploration of fluorescent tracers in the field of nuclear medicine, a need has risen for practical development guidelines that can help improve the translation aspects of fluorescent tracers. This editorial discusses the does and don’ts in developing fluorescence tracers. It has been put forward by the European Association of Nuclear Medicine (EANM) Translational Molecular Imaging & Therapy committee and has been approved by the EANM board.

中文翻译：

---

荧光标记示踪剂的产生-哪些特征会影响翻译潜能？

鉴于在核医学领域对荧光示踪剂的探索日益深入，对实用开发指南的需求不断增加，这些指南可帮助改善荧光示踪剂的翻译方面。这篇社论讨论了在开发荧光示踪剂方面的作为和不作为。它是由欧洲核医学协会（EANM）的转化分子成像与治疗委员会提出的，并已获得EANM理事会的批准。